NathanNLevitanMDMBA

Oncology • Cleveland, OH

Professor of Medicine, Case West Res University

Join to view full profile

Dr. Levitan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levitan's full profile

Already have an account?

Office
17876 Saint Clair Ave
Cleveland, OH 44110
Phone+1 216-383-2222

Fax+1 216-430-2826

Education & Training

UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1984 - 1986
Boston VA Healthcare System (Brockton-West Roxbury)Fellowship, Hematology and Medical Oncology, 1983 - 1984
Boston VA Healthcare System (Brockton-West Roxbury)Residency, Internal Medicine, 1980 - 1983
Tufts University School of MedicineClass of 1980

Certifications & Licensure

OH State Medical License 1991 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1998 Jan 01
Completed
Phase 2
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer Start of enrollment: 1999 Mar 01
Completed
Phase 3
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 1999 Oct 01
Withdrawn
Phase 2
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 1999 Dec 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2001 Sep 01
Completed
Phase 3
Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2003 Oct 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

70 citations
Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients
Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis
Cancer. 2000-04-15
22 citations
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer
Afshin Dowlati, Nathan Levitan, Nahida H. Gordon, Charles L. Hoppel, David M. Gosky
Cancer Chemotherapy and Pharmacology. 2001-01-01
26 citations
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy
Afshin Dowlati, S. Subbiah, Matthew M. Cooney, Kimberly Rutherford, Tarek Mekhail
Lung Cancer. 2007-06-01

Press Mentions

IBM Seeks Niche for Watson for OncologyOctober 15th, 2019
Transform Industry of Real World Evidence Solutions Market Is Estimated to Grow Incredible CAGR Till 2023August 21st, 2019
Industry Voices—Here's How AI Is Impacting Cancer Care Right NowJune 28th, 2019
Join now to see all